Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Global shares edge up, China pulls Asia down, oil subdued pre: OPEC

Jun 21, 2018

By Wayne ColeSYDNEY (Reuters) - Shares crept higher in most major markets on Thursday as a lull in the Sino-U.S. trade tussle and talk of more stimulus in China helped calm nerves, though the nagging trade tensions caused Chinese shares to slip, dragging other Asian markets lower.Oil prices eased a touch as nerves grew ahead of Friday's meeting between OPEC and other big producers, including Russia, with growing expectations that the Vienna talks could result in an agreement to increase crude supplies. [O/R]European shares are expected to rise, with spread-betters calling a higher opening of 0.4 percent in Britain's FTSE...

European autos sink on Daimler tariff hit while markets wilt

Jun 21, 2018

By Helen ReidLONDON (Reuters) - Autos stocks slammed the brakes on a relief bounce in European shares on Thursday, sinking after German carmaker Daimler warned profit would be hit by higher tariffs.The autos sector fell 2.3 percent to a nine-month low while the pan-European STOXX 600 eased down 0.2 percent as no new salvos were exchanged in an ongoing U.S.-China trade spat.Equity markets have been relatively resilient in the face of mounting trade concerns but fell broadly this week as U.S. President Donald Trump threatened additional tariffs on $200 billion worth of Chinese goods.Daimler became one of the biggest global...

May faces down pro-EU rebel lawmakers to win Brexit vote

Jun 21, 2018

By Elizabeth Piper and William JamesLONDON (Reuters) - Prime Minister Theresa May won a crucial Brexit vote in parliament on Wednesday, keeping her divided government's plans to end more than 40 years of British partnership with the European Union on track.After pro-EU Conservative lawmaker Dominic Grieve said he would support the government's proposal for a "meaningful vote" in parliament on Britain's exit, a potential rebellion that could have undermined May's authority was averted.May adopted a high-risk strategy by facing off with rebels in her Conservative Party, and it paid off. The upper house of parliament later approved the bill, paving...

Exclusive: Pope criticizes Trump administration policy on migrant family separation

Jun 21, 2018

By Philip PullellaVATICAN CITY (Reuters) - Pope Francis has criticized the Trump administration's policy of separating migrant families at the Mexican border, saying populism is not the answer to the world's immigration problems.Speaking to Reuters, the Pope said he supported recent statements by U.S. Catholic bishops who called the separation of children from their parents "contrary to our Catholic values" and "immoral"."It's not easy, but populism is not the solution," Francis said on Sunday night.In a rare, wide-ranging interview, the pope said he was optimistic about talks that may lead to a historic agreement over the appointment of bishops in...

Exclusive: Pope says China talks going well, dialogue worth the risk

Jun 21, 2018

By Philip PullellaVATICAN CITY (Reuters) - Pope Francis has voiced optimism for improved ties between the Vatican and China, rejecting criticism that the Holy See may be selling out Catholics to Beijing's communist government.The Vatican and China are in advanced talks to resolve a dispute over the appointment of bishops in China, one of the biggest obstacles to resuming diplomatic ties that were cut almost 70 years ago."We are at a good point," the pope told Reuters in an interview at his Vatican residence.China's estimated 12 million Catholics are split between an underground Church that swears loyalty to the Vatican...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com